Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
0.9% Sodium Chloride (Viaflo)
Sodium chloride 0.9%w/v
Solution for infusion
Baxter Healthcare Limited
Baxter Healthcare Pty Limited, Old Toongabbie, Australia
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Phenasen
Arsenic trioxide 1mg/mL
Concentrate for injection
KSJ Pharmatech Limited
Phebra Pty Limited, Sydney, Australia
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Vosevi
Velpatasvir 100mg
Voxilaprevir 100mg
Sofosbuvir 400mg
Film coated tablet
Gilead Sciences (NZ)
Gilead Sciences Ireland UC, Carrigtohill, Ireland
|
Dated this 25th day of January 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz